A stock price is certainly an estimate of the company's profitability going forward. If COVID vaccines were seen as some endless money maker, then why have the companies that rely almost solely on that for revenue (BioNTech, Moderna, Novavax, etc.) lost 70-95% of their value in the last 1.5 years?
And in this case, there's no evidence of manipulated data or fraud, so the industry's reputation isn't all that relevant. Post-approval monitoring and public health data has been consistent with original trial data.
And that doesn't even get into your conspiracy theory about public health officials promoting vaccination in order to generate more revenue for pharmaceutical companies, rather than as an effective risk mitigation measure.
|